VCAM1 and chronic kidney disease: Atherosclerosis caused by oxidative damage, and evidenced by increased circulating mononuclear superoxide production and vascular cell adhesion molecule-1 (VCAM-1) and triggered by NADPH oxidase (NOx) and NF-kB activation in CKD patients, is associated with IV iron administration [67,68,69,70].